Centanafadine hydrochloride產(chǎn)品詳細(xì)介紹

型號(hào)：

訪問(wèn)量：3636發(fā)布時(shí)間：2021/8/18 單位：MedChemExpress

1
產(chǎn)品概述

Centanafadine hydrochloride產(chǎn)品介紹：
Centanafadine (hydrochloride) 是去甲腎上腺素(NE)/多巴胺(DA)轉(zhuǎn)運(yùn)的雙抑制劑，還能抑制5-羥色胺(serotonin)轉(zhuǎn)運(yùn)體，其對(duì)人 NE，DA 和5-羥色胺轉(zhuǎn)運(yùn)體的IC50值分別為6 nM，38 nM 和 83 nM。

2
產(chǎn)品參數(shù)

Centanafadine hydrochloride產(chǎn)品參數(shù)：
CAS No.：923981-14-0
MCE 際站：Centanafadine hydrochloride
產(chǎn)品活性：Centanafadine (hydrochloride) 是去甲腎上腺素(NE)/多巴胺(DA)轉(zhuǎn)運(yùn)的雙抑制劑，還能抑制5-羥色胺(serotonin)轉(zhuǎn)運(yùn)體，其對(duì)人 NE，DA 和5-羥色胺轉(zhuǎn)運(yùn)體的IC50值分別為6 nM，38 nM 和 83 nM。
研究領(lǐng)域：GPCR/G Protein|Neuronal Signaling
作用靶點(diǎn)：Adrenergic Receptor|Dopamine Transporter|Serotonin Transporter
In Vitro：Centanafadine (EB-1020) preferentially inhibits monoamine reuptake in cloned cell lines transfected with human transporters with IC50 values of 6 and 38 nM, respectively, for NE and DA transporters, Centanafadine has lesser effects on 5-HT transporter as it inhibits the reuptake of 5-HT with an IC50 value of 83 nM .
In Vivo：In microdialysis studies, Centanafadine markedly increases NE, and DA concentrations levels in rat prefrontal cortex in vivo with peak increases of 375 and 300%, respectively with the greatest effects on NE, and also increases DA extracellular concentrations in the striatum to 400% of baseline concentrations. Behavioral studies demonstrate that Centanafadine dose-dependently decreases immobility in the mouse tail suspension test of depression to 13% of control levels, and do not stimulate locomotor activity in adult rats in the optimal dose range.
Centanafadine dose-dependently inhibits locomotor hyperactivity in juvenile rats lesioned with the neurotoxin 6-hydroxydopamine (100 μg intracisternally) as neonates; a well-established animal model for attention-deficit hyperactivity disorder (ADHD).

3
相關(guān)產(chǎn)品

4
品牌介紹

品牌介紹：
MCE (MedChemExpress) 擁有數(shù)百種全球獨(dú)家化合物，我們致力于為全球科研客戶提供zui新zui全的品質(zhì)小分子活性化合物；
10,000 多種選擇性抑制劑、激動(dòng)劑涉及各熱門信號(hào)通路及疾病領(lǐng)域；
設(shè)有業(yè)的實(shí)驗(yàn)中心和嚴(yán)格的質(zhì)控、驗(yàn)證體系；
提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項(xiàng)質(zhì)檢報(bào)告，確保產(chǎn)品的純度、品質(zhì)；
產(chǎn)品的生物活性多經(jīng)各客戶實(shí)驗(yàn)驗(yàn)證；
Nature, Cell, Science 等多種頂級(jí)期刊及制藥利收錄了MCE客戶的科研成果；
業(yè)團(tuán)隊(duì)跟蹤zui新的制藥及生命科學(xué)研究進(jìn)展，為您提供全球zui新的活性化合物；
與世界各大制藥公司及知名科研機(jī)構(gòu)建立了長(zhǎng)期的合作。